Placebo Injection, Retatrutide, Retatrutide, Retatrutide, Retatrutide, Retatrutide
J1I-MC-GZBO
Phase 3 small_molecule active
Quick answer
Placebo Injection, Retatrutide, Retatrutide, Retatrutide, Retatrutide, Retatrutide for Overweight, Obesity is a Phase 3 program (small_molecule) at Eli Lilly Co. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Eli Lilly Co.
- Indication
- Overweight, Obesity
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active